Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Oil's decline continues as inventories rise, demand recovery clouded

Published 03/17/2021, 09:41 PM
Updated 03/18/2021, 04:10 AM
© Reuters. Illustration photo of crude oil being dispensed into a bottle

TOKYO (Reuters) - Oil prices declined for a fifth consecutive session on Thursday falling around 1% after official data showed a further increase in U.S. crude and fuel inventories, while the ever-present pandemic clouded the prospects for a demand recovery.

Brent crude was down 74 cents, or 1.1%, at $67.26 a barrel by 0745 GMT after dropping 0.6% on Wednesday. U.S. oil was also down 65 cents, or 1%, at $63.95 a barrel, having fallen 0.3% the previous session. Both contracts are down around 3% over the last five days of declines.

Government data on Wednesday showed U.S. crude inventories have risen for four straight weeks after refineries in the south were forced to shut due to severe cold weather. An industry report estimating a decline had raised hopes the run of gains might have stopped.

U.S. crude inventories increased by 2.4 million barrels last week, the U.S. Energy Information Administration (EIA) said on Wednesday. That was a day after the American Petroleum Institute (API) on Tuesday estimated a 1 million barrel-decline.

Stocks of gasoline and diesel increased against expectations among analysts for a decline.

"U.S. inventory numbers from the EIA were more bearish than the API numbers from the previous day suggested," ING Economics said, noting the stocks totalled more than 500 million barrels for the first time this year.

"Refiners continue to bring back capacity after the freezing conditions in February," ING said, adding that throughput rates are still below the average before the cold snap.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the demand front, a slowdown in some inoculation programmes and the prospect of more restrictions to control the coronavirus tempered expectations for a recovery in fuel use.

A number of European countries have halted use of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine because of concerns about possible side effects.

Germany is also seeing a rise in coronavirus cases, while Italy plans a national lockdown for Easter lockdown and France will introduce tougher restrictions.

Latest comments

If y cant gwt a job at McDonalds, you work as a journalist for Reuters, CNN main stream media. No qualification needed, only lie and blame all day long
Must get info from Foxy.
what comments are you speaking, specifically, that are false? Help Im trying learn more about this...
the whole wednesday they were telling us about suprise drop and now build...
Fact check.  Partially true.  Oil risen so much that fall of 50 cents doesn't make a difference.
There is no bigger fraud than reports from the federal energy dept while gas prices are on the rise
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.